IP Library Granted Patent US 8,734,468
Granted Patent B2
US 8,734,468 · App. 13/073,763 · Granted May 27, 2014

Devices, systems and methods for treating benign prostatic hyperplasia and other conditions

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,734,468
App. No.
13/073,763
Granted
May 27, 2014
Kind
B2
Abstract

Devices, systems and methods for compressing, cutting, incising, reconfiguring, remodeling, attaching, repositioning, supporting, dislocating or altering the composition of tissues or anatomical structures to alter their positional or force relationship to other tissues or anatomical structures. In some applications, the invention may be used to used to improve patency or fluid flow through a body lumen or cavity (e.g., to limit constriction of the urethra by an enlarged prostate gland).

Claims (19)

1. A method for treating a condition in a human or animal subject wherein the prostate gland is causing undesirable constriction of the urethra, said method comprising the steps of:

A) inserting an introducer device into the subject's body, the introducer device including a projecting member wherein a distal portion of the projecting member is longitudinally advanceable beyond a distal end of the introducer device;

B) advancing a cutting device from the introducer device through the projecting member after the distal portion of the projecting member is advanced beyond a distal end of the introducer device; and

C) using the cutting device to cut at least a portion of the prostate gland such that the constriction of the urethra is lessened, wherein the cut is formed between the lobes of the prostate gland such that the lobes separate from one another.

2. A method according to claim 1 wherein Step A comprises inserting the introducer percutaneously through the abdominal wall.

3. A method according to claim 1 wherein Step A comprises inserting the introducer percutaneously through the perineum.

4. A method according to claim 1 wherein Step A comprises inserting the introducer percutaneously through the abdominal wall, through the wall of the urinary bladder and to a position within the urinary bladder.

5. A method according to 1 wherein Step A comprises percutaneously inserting the introducer through the abdominal wall and though an opening formed in a bone of the pelvis.

6. A method according to claim 1 wherein Step A comprises inserting the introducer into the rectum and wherein the method further comprises advancing either the introducer or the cutting device through an opening formed in the rectal wall.

7. A method according to claim 6 wherein the method further comprises closing the opening formed in the rectal wall.

8. A method according to claim 1 wherein Step B comprises advancing the cutting device through the prostate gland.

9. A method according to claim 1 wherein Step B comprises advancing the cutting device to a position adjacent to the outer surface of the prostate capsule.

10. A method according to claim 1 wherein the cutting element comprises a cutting member that is initially in a non-cutting configuration substantially parallel to a longitudinal axis of the shaft and may be caused to bow outwardly from the shaft thereby cutting tissue as it bows outwardly.

11. A method according to claim 10 wherein the cutting device is advanced into the prostate gland with the cutting member in its non cutting configuration and, thereafter, causing the cutting member to bow outwardly thereby forming a cut in the prostate gland.

12. A method according to claim 11 wherein:

Step A comprises inserting the introducer into the urethra;

Step B comprises advancing the cutting device through the wall of the urethra while the cutting member in its non cutting configuration; and

Step C comprises causing the cutting member to bow outwardly thereby forming a cut in the prostate gland.

13. A method according to claim 12 wherein Step B further comprises advancing a guide from the introducer, through the wall of the urethra and into the prostate gland and thereafter advancing the cutting member in its non cutting configuration.

Assignments (13)
MERGER Recorded Feb 16, 2024
From: TELEFLEX LIFE SCIENCES III LLC
To: TELEFLEX LIFE SCIENCES LLC
Reel/Frame 066621/0980 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 16, 2024
From: TELEFLEX LIFE SCIENCES LIMITED
To: TELEFLEX LIFE SCIENCES III LLC
Reel/Frame 066617/0582 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 15, 2024
From: TELEFLEX LIFE SCIENCES LIMITED
To: TELEFLEX LIFE SCIENCES III LLC
Reel/Frame 066305/0073 →
MERGER Recorded Jan 15, 2024
From: TELEFLEX LIFE SCIENCES III LLC
To: TELEFLEX LIFE SCIENCES LLC
Reel/Frame 066305/0802 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 31, 2022
From: NEOTRACT, INC.
To: TELEFLEX LIFE SCIENCES LIMITED
Reel/Frame 058917/0381 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 27, 2021
From: NEOTRACT, INC.
To: TELEFLEX LIFE SCIENCES LIMITED
Reel/Frame 058592/0907 →
SECURITY INTEREST Recorded Oct 3, 2019
From: NEOTRACT, INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 050619/0780 →
RELEASE OF SECURITY INTEREST Recorded Oct 3, 2017
From: CAPITAL ROYALTY PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "A" L.P.; PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.
To: NEOTRACT, INC.
Reel/Frame 044114/0608 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE DATA PREVIOUSLY RECORDED ON REEL 032212 FRAME 0163. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded May 30, 2017
From: LAMSON, THEODORE CHARLES; MAKOWER, JOSHUA; CATANESE, JOSEPH, III; WELCH, JACQUELINE NERNEY; WALKE, AMRISH JAYPRAKASH; VIDAL, CLAUDE; REDMOND, RUSSELL J.; COLLINSON, MICHAEL
To: EXPLORAMED NC2, INC.
Reel/Frame 042623/0947 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE AND ASSIGNOR PREVIOUSLY RECORDED AT REEL: 032264 FRAME: 0019. ASSIGNOR(S) HEREBY CONFIRMS THE CHANGE OF NAME. Recorded May 30, 2017
From: EXPLORAMED NC2, INC.
To: NEOTRACT, INC.
Reel/Frame 042623/0916 →
SHORT-FORM PATENT SECURITY AGREEMENT Recorded Mar 25, 2014
From: NEOTRACT, INC.
To: CAPITAL ROYALTY PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "A" L.P.; PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.
Reel/Frame 032525/0104 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 13, 2014
From: CATANESE, JOSEPH, III; LAMSON, THEODORE C; VIDAL, CLAUDE; REDMOND, RUSSELL J; COLLINSON, MICHAEL; MAKOWER, JOSHUA; NERNEY WELCH, JACQUELINE; WALKE, AMRISH JAYPRAKASH
To: NEOTRACT, INC
Reel/Frame 032212/0163 →
CHANGE OF NAME Recorded Feb 13, 2014
From: CATANESE, JOSEPH, III; LAMSON, THEODORE C; VIDAL, CLAUDE; REDMOND, RUSSELL J; COLLINSON, MICHAEL; MAKOWER, JOSHUA; NERNEY WELCH, JACQUELINE; WALKE, AMRISH JAYPRAKASH
To: NEOTRACT, INC
Reel/Frame 032264/0019 →